Literature DB >> 26567033

Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".

E Salsitz1, T Wiegand2.   

Abstract

Methadone maintenance therapy (MMT), a pharmacological treatment for opioid use disorder for the past 50 years, continues to remain controversial. Despite consistent and overwhelming evidence confirming the effectiveness and safety of MMT, misconceptions and myths persist regarding its legitimacy as a treatment for opioid addiction. This often results in the underutilization and limited availability of this treatment modality. Despite successful outcomes, the controversial nature of MMT, and the stigma experienced by the patients on methadone, has been a particularly difficult obstacle to overcome. We present the history of MMT, review the evidence for its efficacy in the treatment of opioid dependence, and explore the origins of the stigma and misconceptions related to MMT.

Entities:  

Keywords:  Addiction; Drug dependence; Medication assisted treatment; Methadone; Opioid addiction

Mesh:

Substances:

Year:  2016        PMID: 26567033      PMCID: PMC4781801          DOI: 10.1007/s13181-015-0517-5

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  28 in total

1.  Mortality in heroin addiction: impact of methadone treatment.

Authors:  L Grönbladh; L S Ohlund; L M Gunne
Journal:  Acta Psychiatr Scand       Date:  1990-09       Impact factor: 6.392

2.  Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.

Authors:  Anne Bukten; Svetlana Skurtveit; Michael Gossop; Helge Waal; Per Stangeland; Ingrid Havnes; Thomas Clausen
Journal:  Addiction       Date:  2011-10-26       Impact factor: 6.526

3.  HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Authors:  D C Des Jarlais; S R Friedman; D M Novick; J L Sotheran; P Thomas; S R Yancovitz; D Mildvan; J Weber; M J Kreek; R Maslansky
Journal:  JAMA       Date:  1989-02-17       Impact factor: 56.272

4.  Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.

Authors:  Alexander N Katchman; Kelly A McGroary; Michael J Kilborn; Craig A Kornick; Paolo L Manfredi; Raymond L Woosley; Steven N Ebert
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

Review 5.  Neurobiology of addictive behaviors and its relationship to methadone maintenance.

Authors:  B Stimmel; M J Kreek
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

6.  Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.

Authors:  Evgeny Krupitsky; Edward V Nunes; Walter Ling; Ari Illeperuma; David R Gastfriend; Bernard L Silverman
Journal:  Lancet       Date:  2011-04-30       Impact factor: 79.321

7.  Diminished illicit drug use as a consequence of long-term methadone maintenance.

Authors:  E Gottheil; R C Sterling; S P Weinstein
Journal:  J Addict Dis       Date:  1993

8.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Authors:  V P DOLE; M NYSWANDER
Journal:  JAMA       Date:  1965-08-23       Impact factor: 56.272

9.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

10.  Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.

Authors:  Daniel D Langleben; Kosha Ruparel; Igor Elman; Samantha Busch-Winokur; Ramapriyan Pratiwadi; James Loughead; Charles P O'Brien; Anna R Childress
Journal:  Am J Psychiatry       Date:  2007-12-03       Impact factor: 18.112

View more
  9 in total

Review 1.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

Review 2.  Managing Pain in the Setting of Opioid Use Disorder.

Authors:  Barbara St Marie; Kathleen Broglio
Journal:  Pain Manag Nurs       Date:  2019-10-21       Impact factor: 1.929

3.  Stress, craving and mood as predictors of early dropout from opioid agonist therapy.

Authors:  Leigh V Panlilio; Samuel W Stull; William J Kowalczyk; Karran A Phillips; Jennifer R Schroeder; Jeremiah W Bertz; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; Edward V Nunes; David H Epstein; Kenzie L Preston
Journal:  Drug Alcohol Depend       Date:  2019-07-16       Impact factor: 4.492

4.  Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.

Authors:  Ada Lo; Thomas Kerr; Kanna Hayashi; M-J Milloy; Ekaterina Nosova; Yang Liu; Nadia Fairbairn
Journal:  J Subst Abuse Treat       Date:  2018-08-23

5.  Beyond abstinence and relapse: cluster analysis of drug-use patterns during treatment as an outcome measure for clinical trials.

Authors:  Leigh V Panlilio; Samuel W Stull; Jeremiah W Bertz; Albert J Burgess-Hull; William J Kowalczyk; Karran A Phillips; David H Epstein; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2020-09-29       Impact factor: 4.530

6.  Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates.

Authors:  Samira Samiee-Zafarghandy; Tamara van Donge; Karel Allegaert; John van den Anker
Journal:  Children (Basel)       Date:  2021-02-25

7.  Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.

Authors:  Elissa R Weitzman; Joe Kossowsky; Laura M Blakemore; Rachele Cox; David J Dowling; Ofer Levy; Emma W Needles; Sharon Levy
Journal:  Clin Infect Dis       Date:  2022-08-15       Impact factor: 20.999

Review 8.  Intranasal Insulin: a Treatment Strategy for Addiction.

Authors:  Bhavani Kashyap; Leah R Hanson; William H Frey Ii
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

9.  Diversity inclusion in United States opioid pharmacological treatment trials: A systematic review.

Authors:  Tessa Nalven; Nichea S Spillane; Melissa R Schick; Lisa L Weyandt
Journal:  Exp Clin Psychopharmacol       Date:  2021-07-05       Impact factor: 3.492

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.